Latest / Stock Movers / Moderna Soars, SK Hynix Jumps, Estee Lauder Gains
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: I'm Carol Master along with Emily Graffeo here at Bloomberg.
- 0:19Speaker 1: Let's get to Bloomberg News Managing editor Market's live blog.
- 0:22Speaker 1: Christina Quino, she's here with our stock movers. We got
- 0:26Speaker 1: to start with Maderna. Oh absolutely, I got to check
- 0:28Speaker 1: the numbers of this one because it was just off
- 0:30Speaker 1: the charts.
- 0:31Speaker 3: Yeah, literally off the charts. I mean, we got one
- 0:34Speaker 3: hundred and seventy seven percent increase on that stock DICK
- 0:36Speaker 3: or mRNA by the way, that is a record wise essentially,
- 0:40Speaker 3: and you know some of the numbers that we've seen
- 0:42Speaker 3: today are staggering as well. It added forty four billion
- 0:45Speaker 3: dollars in value. But if you were short, it was
- 0:48Speaker 3: painful because that jump suddenly delivered a five and a
- 0:52Speaker 3: half billion dollar loss to any short sellers. So yeah,
- 0:56Speaker 3: do you.
- 0:56Speaker 1: Wonder how much was shortcovering? Right? How much was the
- 0:59Speaker 1: news itself? Mentally?
- 1:00Speaker 3: I mean you never know, but I mean with something
- 1:03Speaker 3: as big as this, right, So I mean the news
- 1:06Speaker 3: which speaking of let's get to it right. I mean,
- 1:08Speaker 3: a very successful trial, very promising. Essentially it's the first positive,
- 1:13Speaker 3: final saye trial for any mRNA based cancer therapy, and
- 1:17Speaker 3: so really it's kind of a lot of analysts are
- 1:19Speaker 3: thinking like, hey, this is the off round for Maderna
- 1:22Speaker 3: to kind of capitalize on its COVID peak and then
- 1:25Speaker 3: transition that technology into other uses. And of course melanoma
- 1:29Speaker 3: is the deadliest form of skincancer. I didn't even know that,
- 1:32Speaker 3: but you know, there, go it's a.
- 1:33Speaker 1: Wet It is really bad, and I do think about
- 1:37Speaker 1: it's kind of, as they said, a second act for
- 1:40Speaker 1: messenger RNA. It was just so interesting. So you look
- 1:44Speaker 1: at the chart today, it's just like a straight lineup,
- 1:45Speaker 1: which is kind of wild. But what I wanted to
- 1:47Speaker 1: do is just go back to coming off of COVID
- 1:51Speaker 1: at a tide. This was a four hundred and eighty
- 1:54Speaker 1: four dollars a share stock, so it's that one seventy four.
- 1:57Speaker 1: So we know that there has been quite a pullback
- 2:00Speaker 1: as everybody was like these with these drunk makers, it's
- 2:02Speaker 1: all about pipeline, like what do you do next?
- 2:04Speaker 3: Erectly?
- 2:05Speaker 1: So mr NA mRNA, Okay, we'll go to it, we'll
- 2:09Speaker 1: pivot s k Heinex.
- 2:10Speaker 2: I mean, this is a name that's becoming.
- 2:12Speaker 3: More familiar to traders. Yeah, especially because they did do
- 2:16Speaker 3: their US listing not too long ago, right, they raised
- 2:19Speaker 3: quite a bit of money. They're twenty six and a
- 2:21Speaker 3: half billion dollars. But now, of course since then, actually
- 2:24Speaker 3: well over the past two months, we've seen the stock
- 2:26Speaker 3: really like turn lower, fifty percent decline over the past
- 2:29Speaker 3: two months, and so you know they had to do something.
- 2:31Speaker 3: And that's something is buybacks. I mean, what do you
- 2:34Speaker 3: do right if your stock is falling? And so they
- 2:36Speaker 3: did announce plans for a twenty nine billion dollars share buyback.
- 2:40Speaker 3: So so earlier the stock was actually up as much
- 2:42Speaker 3: as five percent, but you know, end of the day
- 2:45Speaker 3: just up three tents one percent. So you know that
- 2:47Speaker 3: it's it's diminishing returns, right, It's not a forever like
- 2:51Speaker 3: boost yours.
- 2:52Speaker 1: It makes me crazy because it's just math. Right, you
- 2:54Speaker 1: reduce the amount of shares, your earnings per share looks better,
- 2:57Speaker 1: and I like, I get it, and I get why
- 2:59Speaker 1: investors like it. Fundamentally, nothing has changed, right.
- 3:01Speaker 3: Absolutely care and especially now because still a lot of
- 3:04Speaker 3: questions over the AI trade, particularly in the hardware space, right,
- 3:08Speaker 3: I mean, how much of that kind of hardware inflation
- 3:10Speaker 3: is going to persist or is it eventually kind of
- 3:13Speaker 3: going to catch up to a lot of the stocks
- 3:15Speaker 3: that benefited from that, But now are kind of seeing
- 3:17Speaker 3: the other side of it.
- 3:18Speaker 1: If I knew, I'd be on the island.
- 3:22Speaker 2: If you really wouldn't be here.
- 3:23Speaker 1: So that's where I would be leading about all this stuff.
- 3:27Speaker 1: Let's go to St. Lauder and iconic cosmetic company. It's
- 3:31Speaker 1: had its ups and downs. So as of late, tickers
- 3:33Speaker 1: e L.
- 3:33Speaker 3: Yeah, absolutely tickers e L. But it's up to day
- 3:36Speaker 3: for sure. A sixteen percent gain. That's the biggest gain
- 3:38Speaker 3: in almost fifteen years. And again, yeah, a good set
- 3:41Speaker 3: of results of fourth quarter revenue beating estimates organic sales
- 3:44Speaker 3: of five percent. And another feature of their turnaround, of course,
- 3:49Speaker 3: is restructuring in headcount reduction. So they did say that
- 3:52Speaker 3: they're looking to do a net reduction of ten thousand
- 3:55Speaker 3: positions a lot. Yeah, that is that is going to
- 3:57Speaker 3: be at but it seems pivotal for the company.
- 4:00Speaker 1: Right.
- 4:00Speaker 3: It's been trying to turn itself around for a couple
- 4:02Speaker 3: of years now, and you know the CEO's fun Del
- 4:05Speaker 3: Favaret tells our very own remain Bostic earlier with twenty
- 4:08Speaker 3: twenty six is all about promises made and promises kept.
- 4:12Speaker 1: So they have forty thousand employees and they're cutting ten thousand.
- 4:16Speaker 3: Ten thousand positions net reduction workforce. Wow, big one.
- 4:22Speaker 1: Yeah, they were hurt a lot too by Asia for
- 4:23Speaker 1: a long time, right.
- 4:24Speaker 3: Absolutely, Yeah, I mean it was very big in Asia,
- 4:28Speaker 3: and you know, the advanced night repair very popular when
- 4:30Speaker 3: I was. When I was over there.
- 4:33Speaker 1: A lovely aunt, aunt Merril, who worked for STI Lauder
- 4:36Speaker 1: years ago, and so we grew up as kid like
- 4:38Speaker 1: that was like my first clinique and origin. Yeah, she
- 4:43Speaker 1: used to bring us all these little gifts and it
- 4:44Speaker 1: was just a super super treatment. But it was There's
- 4:47Speaker 1: a lot more competition out there.
- 4:48Speaker 3: That's absolutely.
- 4:52Speaker 2: The stock mover's Report from Bloomberg Radio. Check back with
- 4:56Speaker 2: us throughout the day for the latest roundup of companies
- 4:58Speaker 2: making news on Wall Street and for the latest market
- 5:02Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 5:06Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 5:10Speaker 2: the Bloomberg Business app.